Targeted Oncology: a target for oncologists Jean-François MorèreEric Van Cutsem Editorial 06 January 2006 Pages: 1 - 1
Targeted therapies for patients with advanced colorectal cancer: focus on cetuximab E. Van CutsemR. LabiancaJ. Tabernero Clinical Review 10 January 2006 Pages: 2 - 12
Targeted therapies in the treatment of advanced non-small cell lung cancer elderly patients C. GridelliP. MaioneC. Guerriero Clinical Review 04 January 2006 Pages: 13 - 22
Emerging strategies in the treatment of advanced esophageal, gastroesophageal junction, and gastric cancer: the introduction of targeted therapies T. MacarullaC. ValverdeA. Cervantes Clinical Review 10 January 2006 Pages: 23 - 33
Histone deacetylase inhibitors as a potential therapeutic agent for human cancer treatment G. KouraklisE. P. MisiakosS. Theocharis Perspectives 04 January 2006 Pages: 34 - 41
Protein kinase C α and δ are members of a large kinase family of high potential for novel anticancer targeted therapy A. GhoulM. SerovaE. Raymond Perspectives 11 January 2006 Pages: 42 - 53
Stable disease for four years in metastatic malignant melanoma treated with the heat shock protein inhibitor 17-AAG J. SpicerU. BanerjiI. Judson Case Report 03 January 2006 Pages: 54 - 55
Erlotinib in a previously treated advanced non-small cell lung cancer elderly patient: a clinical case C. GridelliA. RossiG. Colantuoni Case Report 04 January 2006 Pages: 56 - 58
The 41st annual ASCO meeting: targeted therapies, Orlando, Florida G. Des Guetz Meeting Report 11 January 2006 Pages: 59 - 65
AACR - NCI - EORTC international conference on molecular targets and cancer therapeutics: highlights J. F. Morère Meeting Report 04 January 2006 Pages: 66 - 67
